U.S. Reps. Raja Krishnamoorthi, D-Ill., and Earl “Buddy” Carter, R-Ga., along with nine other representatives, introduced a bipartisan PBM Reform Act, with regulations centered around Medicare and ...

FTC investigators documented how pharmacy benefit managers imposed eye-popping markups on generic drugs used to treat deadly ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Kentucky’s independent pharmacies, facing ongoing financial pressure, had hoped for relief from a new law meant to give them ...

Kentucky’s independent pharmacies, facing ongoing financial pressure, had hoped for relief from a new law meant to give them ...

Kentucky law to give independent pharmacies financial relief from pharmaceutical industry middlemen has stalled in state ...

Healthcare analyst Ellen Andrews, Ph. D, highlights a first-in-the-nation bill that the state passed this year in an effort to control generic drug prices.

The U.S. Federal Trade Commission is seeking more details about SoftBank Group Corp's planned $6.5 billion purchase of ...

The Federal Trade Commission (FTC), charged with protecting the American consumer, on January 15, 2025, issued a special report on PBMs. It found they are as profit driven as pharma.

AG Liz Murrill explains why Louisiana filed three major lawsuits against CVS over controversial text messages and business practices harming patients.

A coalition of Iowa business interests are suing the state to stop a law restricting pharmacy benefit managers (PBMs).

The “big three” pharmacy benefit managers have imposed markups ranging from 100% to more than 7,000% on generic specialty drugs dispensed at their affiliated pharmacies, according to a ...